ESR1 and breast carcinoma: MMTV‐Neu mice have been used for modeling epidermal growth factor receptor 2 (HER2)‐positive breast cancer, whereas MMTV‐CyclinD1 for estrogen receptor (ER)‐positive breast cancer.